- Federal Court Rejects Patents of Human Genes, Friends of the Earth Asks Congress to Make Ruling Permanent
Federal Court Rejects Patents of Human Genes, Friends of the Earth Asks Congress to Make Ruling Permanent
Your contribution will benefit Friends of the Earth.
Thanks for your interest in Friends of the Earth. You can find information about us and get in touch the following ways:
The U.S. District Court of New York held yesterday in Association for Molecular Pathology, et al. v U.S. Patent and Trademark Office, et al. that patents on human genes that correlate with increased risk for breast cancer and ovarian cancer are invalid since genes and DNA sequences are naturally occurring.
Friends of the Earth, which has long fought gene patenting, praised the ruling and called on members of Congress to respond by passing the Genomic Research and Accessibility Act, which would codify the court’s decision in legislation. Eric Hoffman, Genetic Technology Policy Campaigner for Friends of the Earth said: “This ruling is a huge victory for women who will no longer have to pay exorbitant fees for cancer screening, and it’s a victory for the effort to stop the patenting of life at all levels. Judge Sweet’s decision in this case draws a clear line that all genes and DNA sequences are naturally occurring and therefore outside the scope of patentability. This ruling will help countless people receive medical tests without having to pay exorbitant prices to private corporations that have want to patent genes they did not invent. “The defendants will likely appeal this case all the way to the Supreme Court. That is one reason it is incumbent upon Congress to pass the Genomic Research and Accessibility Act. All genes and DNA sequences, whether they are isolated or remain in the body, should forever stay in the public domain. We should never again allow private firms to own naturally occurring genes and DNA sequences at the expense of public health.” Contact: Eric Hoffman, [email protected]